News Overview Diversity & Sustainability News SearchSortA-ZZ-AOldestNewestSort A-ZZ-AOldestNewestPortfolioAorticCardiacPeripheralPortfolio AorticCardiacPeripheral 22 Results 06/2023 GORE INITIATES STUDY TO COMPARE THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS TO BARE METAL STENTS The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare...See more 11/2022 GORE INITIATES THE RELIEF CLINICAL STUDY EVALUATING PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF The Gore RELIEF study is evaluating the safety and efficacy of transcatheter closure of patent...See more 04/2022 GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS FLAGSTAFF, Ariz. (APRIL 12, 2022) — Gore Medical has received Breakthrough Device designation...See more 01/2024 GORE RECEIVES FDA APPROVAL FOR BREAKTHROUGH ENDOVASCULAR DEVICE IN COMPLEX AORTIC ANEURYSMS First off-the-shelf solution for treatment of complex aneurysmal disease involving the visceral...See more 03/2021 GORE REDUCE CLINICAL STUDY FIVE-YEAR RESULTS DEMONSTRATE THAT PFO CLOSURE WITH THE GORE® CARDIOFORM SEPTAL OCCLUDER PROVIDES SAFE LONG-TERM REDUCTION OF RECURRENT STROKE FLAGSTAFF, Ariz. (March 11, 2021)— W. L. Gore & Associates (Gore), today announced that Gore...See more 01/2022 GORE® CARDIOFORM SEPTAL OCCLUDER MARKS 10 YEARS OF IMPROVING LIVES FLAGSTAFF, Ariz. (JAN. 19, 2022) — W. L. Gore & Associates (Gore) today announced that the GORE®...See more 04/2024 NOW INDICATED FOR AAA PATIENTS WITH HIGHLY ANGULATED NECKS W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE®...See more 10/2023 THE GORE RELIEF CLINICAL STUDY BEGINS RANDOMIZING PATIENTS TO EVALUATE PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF The Gore RELIEF Clinical Study is evaluating the safety and efficacy of transcatheter closure of...See more 11/2020 W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE FLAGSTAFF, Ariz. (November 18, 2020) — W. L. Gore & Associates, Inc. (Gore), a global leader in...See more 09/2020 W. L. Gore & Associates enhances GORE® VIABAHN® Endoprosthesis portfolio with lower profile delivery FLAGSTAFF, Ariz – September 22, 2020 – As part of efforts to continuously improve medical...See more Load More Media Contacts Jessica MoranArizona, United States+1 480 601 4799jmoran@wlgore.comHenrietta BryanUnited Kingdom+44 (0) 7867 90 6287hbryan@wlgore.com Top
06/2023 GORE INITIATES STUDY TO COMPARE THE GORE® VIABAHN® VBX BALLOON EXPANDABLE ENDOPROSTHESIS TO BARE METAL STENTS The Gore VBX FORWARD Clinical Study aims to compare the VBX Stent Graft primary patency to bare...See more
11/2022 GORE INITIATES THE RELIEF CLINICAL STUDY EVALUATING PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF The Gore RELIEF study is evaluating the safety and efficacy of transcatheter closure of patent...See more
04/2022 GORE MEDICAL RECEIVES BREAKTHROUGH DEVICE DESIGNATION FOR THE GORE® EXCLUDER® THORACOABDOMINAL BRANCH ENDOPROSTHESIS FLAGSTAFF, Ariz. (APRIL 12, 2022) — Gore Medical has received Breakthrough Device designation...See more
01/2024 GORE RECEIVES FDA APPROVAL FOR BREAKTHROUGH ENDOVASCULAR DEVICE IN COMPLEX AORTIC ANEURYSMS First off-the-shelf solution for treatment of complex aneurysmal disease involving the visceral...See more
03/2021 GORE REDUCE CLINICAL STUDY FIVE-YEAR RESULTS DEMONSTRATE THAT PFO CLOSURE WITH THE GORE® CARDIOFORM SEPTAL OCCLUDER PROVIDES SAFE LONG-TERM REDUCTION OF RECURRENT STROKE FLAGSTAFF, Ariz. (March 11, 2021)— W. L. Gore & Associates (Gore), today announced that Gore...See more
01/2022 GORE® CARDIOFORM SEPTAL OCCLUDER MARKS 10 YEARS OF IMPROVING LIVES FLAGSTAFF, Ariz. (JAN. 19, 2022) — W. L. Gore & Associates (Gore) today announced that the GORE®...See more
04/2024 NOW INDICATED FOR AAA PATIENTS WITH HIGHLY ANGULATED NECKS W. L. Gore & Associates (Gore) announces FDA approval of an expanded indication for the GORE®...See more
10/2023 THE GORE RELIEF CLINICAL STUDY BEGINS RANDOMIZING PATIENTS TO EVALUATE PFO CLOSURE FOR MIGRAINE HEADACHE RELIEF The Gore RELIEF Clinical Study is evaluating the safety and efficacy of transcatheter closure of...See more
11/2020 W. L. GORE & ASSOCIATES ANNOUNCES ENCOURAGING SIX-MONTH RESULTS WITH ITS NOVEL BIOSYNTHETIC TISSUE VALVE FLAGSTAFF, Ariz. (November 18, 2020) — W. L. Gore & Associates, Inc. (Gore), a global leader in...See more
09/2020 W. L. Gore & Associates enhances GORE® VIABAHN® Endoprosthesis portfolio with lower profile delivery FLAGSTAFF, Ariz – September 22, 2020 – As part of efforts to continuously improve medical...See more